Nikolaos Svoronos

Hematology | Oncology

1400 Forest Glen Rd Ste 335
Silver Spring, MD 20910

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Disruption of Notch signaling by KGF induces a developmental pause in thymocytes.

Disruption of Notch signaling by KGF induces a developmental pause in thymocytes.

Journal: Frontiers in immunology

Published: July 29, 2025

Philadelphia chromosome-like B-acute lymphoblastic leukemia and disseminated juvenile xanthogranulomatosis with shared KRAS mutation.

Philadelphia chromosome-like B-acute lymphoblastic leukemia and disseminated juvenile xanthogranulomatosis with shared KRAS mutation.

Journal: Pediatric blood & cancer

Published: February 21, 2024

IL-33 delays metastatic peritoneal cancer progression inducing an allergic microenvironment.

IL-33 delays metastatic peritoneal cancer progression inducing an allergic microenvironment.

Journal: Oncoimmunology

Published: April 18, 2018

Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations.

Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: April 10, 2018

Frontline Science: Microbiota reconstitution restores intestinal integrity after cisplatin therapy.

Frontline Science: Microbiota reconstitution restores intestinal integrity after cisplatin therapy.

Journal: Journal of leukocyte biology

Published: November 15, 2017

Estrogens drive myeloid-derived suppressor cell accumulation.

Estrogens drive myeloid-derived suppressor cell accumulation.

Journal: Oncoscience

Published: January 30, 2017

Trametinib Drives T-cell-Dependent Control of KRAS-Mutated Tumors by Inhibiting Pathological Myelopoiesis.

Trametinib Drives T-cell-Dependent Control of KRAS-Mutated Tumors by Inhibiting Pathological Myelopoiesis.

Journal: Cancer research

Published: May 09, 2016

Tumor Cell-Independent Estrogen Signaling Drives Disease Progression through Mobilization of Myeloid-Derived Suppressor Cells.

Tumor Cell-Independent Estrogen Signaling Drives Disease Progression through Mobilization of Myeloid-Derived Suppressor Cells.

Journal: Cancer discovery

Published: May 02, 2016

Follicle-Stimulating Hormone Receptor Is Expressed by Most Ovarian Cancer Subtypes and Is a Safe and Effective Immunotherapeutic Target.

Follicle-Stimulating Hormone Receptor Is Expressed by Most Ovarian Cancer Subtypes and Is a Safe and Effective Immunotherapeutic Target.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 24, 2016

BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression.

BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression.

Journal: Cell reports

Published: February 16, 2016

IL15 Agonists Overcome the Immunosuppressive Effects of MEK Inhibitors.

IL15 Agonists Overcome the Immunosuppressive Effects of MEK Inhibitors.

Journal: Cancer research

Published: October 08, 2015

Satb1 Overexpression Drives Tumor-Promoting Activities in Cancer-Associated Dendritic Cells.

Satb1 Overexpression Drives Tumor-Promoting Activities in Cancer-Associated Dendritic Cells.

Journal: Cell reports

Published: September 16, 2015

Showing 1-12 of 20

Last Updated: 09/26/2026